Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 16, 15:58
2089.15
-228.3 (-9.85%)
VOLUME 323,759
LIVE
NSE
Jul 16, 15:59
2093.95
-225.9 (-9.74%)
VOLUME 3,721,516
News on Dr Reddys Laboratories
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
D-Street Buzz: Over 131 stocks hit new 52-week low on NSE with PC Jeweller down 20%, RIL slips 2%

10.08 am | 16 Jul 2018 |  Source: Moneycontrol.com

131 stocks have hit fresh 52-week low including Ambuja Cements, Andhra Bank, Bank of India, Bharat Heavy Electricals, Can Fin Homes, Cummins India, Fe...

Dr Reddy's slips over 10% after US Court order on Suboxone; global brokerages' reactions mixed

9.56 am | 16 Jul 2018 |  Source: Moneycontrol.com

New Jersey District Court converted a temporary injunction into a preliminary injunction against the company that prevents it from launching generic S...

Stocks in the news: Tata Motors, Infosys, HUL, Vedanta, Aurobindo Pharma, JSPL, Just Dial

7.49 am | 16 Jul 2018 |  Source: Moneycontrol.com

Infosys | Vedanta | Dr Reddy's Laboratories | Aurobindo Pharma | PC Jeweller | Minda Industries | Inter Globe Finance | JSPL | Fortune Financial S...

Dr Reddy's to appeal US court's preliminary injunction against launch of generic Suboxone

8.13 pm | 14 Jul 2018 |  Source: Moneycontrol.com

The company has been prevented from re-launching its generic Suboxone until it prevails in an appeal of this injunction...

Dr Reddy's launches generic version of Plaquenil in US

1.03 pm | 11 Jul 2018 |  Source: PTI

Quoting IMS Health data, Dr Reddy's Laboratories the Plaquenil brand and generic had US sales of approximately USD 215 million for the most recent...

Dr Reddy's ties up with UCB to market epilepsy drug in India

8.15 pm | 09 Jul 2018 |  Source: PTI

The drug is approved as an adjunctive therapy for the treatment of partial-onset seizures in epilepsy patients who are 16 years of age and older....

Dr Reddy's Laboratories up 3% on agreement with UCB to distribute Briviact in India

3.17 pm | 09 Jul 2018 |  Source: Moneycontrol.com

The company has entered into a distribution and co-promotion agreement with UCB for Briviact, a brand of brivaracetam....

Trade Setup for Tuesday: Top 15 things to know before Opening Bell

7.05 am | 03 Jul 2018 |  Source: Moneycontrol.com

Formation of a Dark Cloud Cover after a bullish candle does not augur well for the bulls and traders should avoid short term bets for the time being, ...

Buy Dr Reddys Laboratories; target of Rs 3350: Edelweiss

3.42 pm | 29 Jun 2018 |  Source: Moneycontrol.com

Edelweiss bullish on Dr Reddys Laboratories has recommended buy rating on the stock with a target price of Rs 3350 in its research report dated June 2...

Buy Dr Reddy’s Laboratories, target Rs 2450: Aditya Agarwal

2.18 pm | 29 Jun 2018 |  Source: Moneycontrol.com

We advocate traders to buy this stock at the current level of Rs 2,300 – 2,280 with a price target of Rs 2,450 and stop loss placed at Rs 2,175, say...

US court extends restraining order on DRL for selling Suboxone

8.53 am | 29 Jun 2018 |  Source: Moneycontrol.com

Indivior, the innovator of the drug, had moved an injunction motion against Dr Reddy's to block the company from selling generic Suboxone in US...

Dr Reddy's gets EIR from USFDA for 2 units at Medak

4.19 pm | 28 Jun 2018 |  Source: PTI

In an earlier filing to the bourses on March 9, the drug firm had said it had received five observations from the US Food and Drug Administration (USF...

Buy Dr Reddy's Laboratories, target Rs 2330: Mustafa Nadeem

11.30 am | 28 Jun 2018 |  Source: Moneycontrol.com

We recommend buying the stock at the current level for a target of Rs 2,330 and a stop loss of below Rs 2,245 on a closing basis on the daily chart, s...

Podcast | Stock Picks of the Day: Dr Reddy’s, Tech Mahindra among top 3 intraday trading ideas

10.01 am | 28 Jun 2018 |  Source: Moneycontrol.com

Investors need to watch the movement of Nifty in the first few hours of trade on Thursday as it may be volatile and the pain may intensify to lower le...

Dr Reddy's stock gains 1% on Establishment Inspection Report from USFDA for Medak units

9.50 am | 28 Jun 2018 |  Source: Moneycontrol.com

The US health regulator had completed audit of API Hyderabad Plant 3 at Bollaram and API Hyderabad Plant 1 at Jinnaram Mandal, Medak District, Telanga...

Indian pharma cos may soon find a way to the lucrative Chinese market

6.34 pm | 19 Jun 2018 |  Source: Moneycontrol.com

Currently it takes around five years to get an approval in China, while Indian drug regulator approves drug product within 3-6 months....

Dr Reddy's Laboratories launches anti-epilepsy drug in US market

5.10 pm | 19 Jun 2018 |  Source: PTI

In a press release, Dr Reddy's said, "The drug has been approved by the US Food and Drug Administration (USFDA)."...

Buy Dr Reddy’s Labs: Akash Jain

2.46 pm | 18 Jun 2018 |  Source: Moneycontrol.com

Investors can consider this company with a 3 year horizon. Its earnings performance is dependent upon timely approvals of products in its pipeline, sa...

Trade Setup for Monday: Top 15 things to know before Opening Bell

7.32 am | 18 Jun 2018 |  Source: Moneycontrol.com

Investors are advised to remain cautious and await for a breakout or a breakdown before initiating fresh positions....

US court restrains Dr Reddy's from selling generic de-addiction drug Suboxone

2.57 pm | 16 Jun 2018 |  Source: Moneycontrol.com

The court has scheduled an expedited hearing of the preliminary injunction on June 28, and a ruling is expected soon thereafter...

1 2 3
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.